Regenerative cell therapy product for cartilage defects soon available for patients in Singapore

As part of the ReLive Biotechnologies Group, CO.DON is happy to see that our regenerative cell therapy product for cartilage defects will soon be available for patients in Singapore. What a great success! Since 2021, ReLive and CO.DON are collaborating closely to make this treatment option available to patients in Asia.

read more